Protherics Plc - Report of Foreign Issuer (6-K)
August 14 2008 - 1:28PM
Edgar (US Regulatory)
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C.
20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
Pursuant to Rule 13a-16 or 15d-16
of
the Securities Exchange Act of 1934
14 August 2008
PROTHERICS PLC
(Translation of Registrant’s Name Into
English)
The Heath Business & Technical Park
Runcorn, Cheshire, W47 4QF England
(Address of Principal Executive Offices)
Indicate by check mark whether the registrant files
or will file annual reports under cover of Form 20-F or Form 40-F.
Form
20-F
X
Form
40-F
Indicate by check mark if the registrant is
submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):
Indicate by check mark if the registrant is
submitting the Form 6-K in paper as permitted by Regulation S-T Rule 191(b)(7):
Indicate by check mark whether the registrant by
furnishing the information contained in this form is also thereby furnishing the
information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act
of 1934.
Yes
No
X
If “Yes” is marked, indicate below the
file number assigned to the registrant in connection with Rule 12g3-2(b):
82-
.
The Registrant is furnishing a copy of its
announcements as reported to the Company Announcements Office of the London Stock
Exchange.
Notification of Major Interest in Shares
Lon
don, UK; Brentwood, TN, US;
14
August 2008
-
Protherics PLC ("Protherics" or the "Company"), the
international biopharmaceutical company focused on critical care an
d cancer, announces
that
, on 12 August 2008,
the following notification
of interest in the ordinary share capital of the
Company
was received
today
from Aviva plc
.
|
1
. Reason for the notification
(please tick the appropriate box or boxes)
|
|
An acquisitio
n
voting rights
|
|
An acquisition or disposal of financial instruments
which may result in the acquisition of shares already issued to
w
hich voting rights are attached
|
|
An event changing the breakdown of
voting rights
|
|
|
Other (please
s
pecify
): CHANGE TO THE TOTAL NUMBER OF VOTING RIGHTS IN
ISSUE
|
|
2
. Full name of person(s) subject to the
notification obligation:
|
Aviva plc & its subsidiaries
|
3
. Full name of shareholder(s)
(if different from 2
.):
|
BNY Norwich Union Nominees Limited
6,741,190
*
Chase GA Group Nominees
Limited
18,382,959
*
Chase Nominees Limited
979,009
*
CUIM Nominee Limited
4,812,551
*
Vida
cos Nominees Limited
70,303
*
BNP Paribas -
London
636,429
Chase Nominees Limited
3,518,325
State Street Nominees Limited
9,577,375
Vidacos Nominees Limited
2,003
,
920
|
4
. Date of the transaction (and date on which the
threshold is crossed or reached if different):
|
|
5
. Date on which issuer notified:
|
|
6
. Threshold(s) that is/are crossed or
reached:
|
8% to 9
% Change at
Direct
Interest level
|
|
|
|
A: Voting rights attached to shares
|
if possible using the ISIN CODE
|
Situation previous to the Triggering
transaction
|
Resulting situation after the triggering
transaction
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Resulting situation after the triggering
transaction
|
Type of financial instrument
|
|
Exercise/ Conversion Period/ Date
|
Number of voting rights that may be acquired if
the instrument is exercised/ converted.
|
|
|
|
|
|
8
.
Chain of controlled undertakings through which the
voting rights and/or the financial instruments are effectively held, if
applicable :
|
|
|
|
|
9
. Name of the proxy holder:
|
|
1
0
. Number of voting rights proxy holder will cease
to hold:
|
|
11
. Date on which proxy holder will cease to hold
voting rights:
|
|
12
. Additional information:
|
Figures are based on a total
number of voting rights of 3
42
,
159
,
034
|
F
or f
urther
i
nformation
please contact
:
|
|
|
Nick Staples
,
Director of Corporate
Affairs
|
|
Julie Vickers, Company Secretary
|
|
|
|
|
Financial Dynamics
- press enquiries
|
|
London:
Ben Atwell, Lara Mott
|
|
New York
:
John Capodanno
|
|
Or visi
t
www.protherics.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.
|
|
|
|
|
|
|
|
|
|
|
PROTHERICS PLC
|
|
|
|
|
|
|
|
|
|
Date: 14 August 2008
|
|
By:
|
|
/s/ Rolf Soderstrom
|
|
|
|
|
|
Rolf Soderstrom
|
|
|
|
|
|
Finance Director
|
Protherics (NASDAQ:PTIL)
Historical Stock Chart
From Jun 2024 to Jul 2024
Protherics (NASDAQ:PTIL)
Historical Stock Chart
From Jul 2023 to Jul 2024
